Endoplasmic Reticulum Stress Inhibition Promotes Mitophagy via Miro1 Reduction to Rescue Mitochondrial Dysfunction

Yuqi Wen1, Zheng Han1,2, Bao Wang1,3

  • 1Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, 569 Xinsi Road, Xi'an, 710038, Shaanxi, China.

Insights

Endoplasmic reticulum stress (ERS) contributes to Parkinson's disease (PD) pathogenesis by impairing mitochondria. Suppressing ERS with 4-phenylbutyric acid (4-PBA) protects neurons and improves motor function in PD models.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Mitochondrial dysfunction and endoplasmic reticulum stress (ERS) are implicated in Parkinson's disease (PD) pathogenesis.
  • The precise regulatory mechanisms linking ERS and mitochondrial dysfunction in PD remain elusive.

Purpose of the Study:

  • To investigate the relationship between ERS and mitochondrial dysfunction in a Parkinson's disease model.
  • To evaluate the therapeutic potential of targeting ERS in PD.

Main Methods:

  • Utilized an in vitro Parkinson's disease model induced by methyl-4-phenylpyridine (MPP+).
  • Assessed ERS using ER staining and immunofluorescence for ERS-related proteins.
  • Examined ER morphology via transmission electron microscopy (TEM).
  • Investigated the effects of 4-phenylbutyric acid (4-PBA) on apoptosis, ER morphology, mitochondrial function, and the Miro1-mitophagy axis.
  • Conducted in vivo experiments in PD models.

Main Results:

  • MPP+-induced PD models exhibited increased intracellular peroxidation and significant ERS with ER depletion.
  • 4-PBA treatment suppressed ERS, reduced apoptosis, and restored ER micromorphology.
  • 4-PBA alleviated mitochondrial dysfunction, evidenced by increased mitochondrial membrane potential (MMP), upregulated electron transport chain proteins, and restored mitochondrial integrity.
  • The therapeutic effects of 4-PBA were linked to modulation of the Miro1-mitophagy axis.
  • Inhibition of ERS in vivo reduced dopaminergic neuron loss and improved cognitive and motor functions.

Conclusions:

  • ERS plays a critical role in the pathogenesis of Parkinson's disease.
  • Targeting ERS, for example, with 4-PBA, offers a promising therapeutic strategy for PD by mitigating mitochondrial dysfunction and neurodegeneration.

Related Concept Videos

Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
12.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
995
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.6K